Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract Surgery
Study Details
Study Description
Brief Summary
The doctors participating in this study are looking to show improved vision with the HOYA AF-1 aspheric intraocular lens after cataract surgery. They will also study the use of Revital Vision (neuro-sensory testing) in providing the highest potential for improved vision.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Hoya AF-1 IOL
|
Device: Hoya AF-1 IOL
The patients will be assessed for three months
|
Other: Revital Vision
|
Device: Revital vision
The patients will be assessed for three months.
|
Outcome Measures
Primary Outcome Measures
- Measuring Ocular Dominance [3 months]
- Overall post surgical outcomes [3 months]
Secondary Outcome Measures
- Measuring visual acuities [3 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients must desire to pursue some type of mono-vision fit, mono-vision lasik, or mono-vision cataract surgery with lens implant.
-
Patients must be candidates for intraocular lens implantation for the correction of aphakia following extracapsular cataract extraction by phaco-emulsification.
-
Patients must be candidates for bilateral implantation and desiring post-operative spectacle independence through targeted mono-vision.
-
Patients must have less than 1.50 diopters of corneal astigmatism
-
Patients must have the potential for best corrected visual acuity of 20/30 or better in each eye.
-
Patients must have the mental capacity to cooperate when undergoing a detailed postoperative refractive examination.
-
Patients must be an adult.
-
Patients must provide written informed consent for cataract surgery.
-
Patients must be willing and able to return for scheduled follow-up examinations for a period of 3 months (post-second eye) post-operatively.
-
Patients must be willing and able to provide feedback to various survey questions regarding overall satisfaction and ease of adaptation to mono-vision and range of vision, etc.
Exclusion Criteria:
-
Patients with 1.50 diopters or more of corneal astigmatism
-
Patients requiring a lens power less than 6 D or greater than 30 D
-
Patients with any anterior segment pathology (chronic uveitis, iritis, iridocyclitis, rubeosis iridis, corneal dystrophy or corneal degeneration, tear film deficiency, poor pupil dilation, etc.).
-
Patients with uncontrolled glaucoma or who require current treatment for glaucoma, or with visual field loss as a result of glaucoma.
-
Patients with retinal pathology or a history of retinal detachment.
-
Patients with proliferative diabetic retinopathy, macular degeneration, or other degenerative visual disorders.
-
Patients with a history of previous ocular surgery including corneal refractive surgery.
-
Patients with congenital bilateral cataracts.
-
Patients with marked microphthalmos or aniridia.
-
Patients who have only one functioning eye.
-
Patients who do not have the potential for visual acuity of 20/30 or better in each eye.
-
Patients lacking intact binocular vision.
-
Patients who do not have an intact capsulorhexis and posterior capsular bag at the time of cataract removal and lens implantation.
-
Patients who have incomplete or damaged zonules, or who have zonular rupture during cataract removal.
-
Patients with pupils greater than 7mm
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | McDonald Eye Associates, PA | Fayetteville | Arkansas | United States |
Sponsors and Collaborators
- Innovative Medical
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Hoya AF-1